These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 10970940

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison's disease: a randomized clinical trial.
    Oksnes M, Björnsdottir S, Isaksson M, Methlie P, Carlsen S, Nilsen RM, Broman JE, Triebner K, Kämpe O, Hulting AL, Bensing S, Husebye ES, Løvås K.
    J Clin Endocrinol Metab; 2014 May; 99(5):1665-74. PubMed ID: 24517155
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. BclI polymorphism of the glucocorticoid receptor gene is associated with increased bone resorption in patients on glucocorticoid replacement therapy.
    Koetz KR, van Rossum EF, Ventz M, Diederich S, Quinkler M.
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):831-7. PubMed ID: 23134110
    [Abstract] [Full Text] [Related]

  • 25. Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy.
    Björnsdottir S, Øksnes M, Isaksson M, Methlie P, Nilsen RM, Hustad S, Kämpe O, Hulting AL, Husebye ES, Løvås K, Nyström T, Bensing S.
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):28-35. PubMed ID: 25400085
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease.
    Zelissen PM, Croughs RJ, van Rijk PP, Raymakers JA.
    Ann Intern Med; 1994 Feb 01; 120(3):207-10. PubMed ID: 8273983
    [Abstract] [Full Text] [Related]

  • 28. [Spontaneous remission of corticosteroid osteopenia after successful surgical treatment of Cushing's syndrome. A cross-sectional study].
    Stĕpán J, Weiss V, Marek J, Krsek M, Masatová A, Hána V.
    Cas Lek Cesk; 1997 Jul 30; 136(15):464-7. PubMed ID: 9340192
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Glucocorticoid replacement therapy is independently associated with reduced bone mineral density in women with hypopituitarism.
    Ragnarsson O, Nyström HF, Johannsson G.
    Clin Endocrinol (Oxf); 2012 Feb 30; 76(2):246-52. PubMed ID: 21767286
    [Abstract] [Full Text] [Related]

  • 32. Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison's disease.
    Giordano R, Guaraldi F, Marinazzo E, Fumarola F, Rampino A, Berardelli R, Karamouzis I, Lucchiari M, Manetta T, Mengozzi G, Arvat E, Ghigo E.
    Endocrine; 2016 Feb 30; 51(2):360-8. PubMed ID: 26184416
    [Abstract] [Full Text] [Related]

  • 33. Associated autoimmunity in Addison's disease.
    Zelissen PM, Bast EJ, Croughs RJ.
    J Autoimmun; 1995 Feb 30; 8(1):121-30. PubMed ID: 7734032
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.